Response to peginterferon-alpha 2b and ribavirin in Japanese patients with chronic hepatitis C genotype 1

被引：0
|
作者：
Tomoo Miyauchi
Tatsuo Kanda
Fumio Imazeki
Rintaro Mikata
Akinobu Tawada
Makoto Arai
Keiichi Fujiwara
Shingo Nakamoto
Shuang Wu
Takeshi Tanaka
Tatsuo Miyamura
Michio Kimura
Yasuo Hirai
Motohide Takashi
Shigeru Mikami
Nobuyuki Sugiura
Yutaka Natsuki
Ryosaku Azemoto
Noriaki Suzuki
Osamu Yokosuka
机构：
[1] Chiba University,Department of Medicine and Clinical Oncology, Graduate School of Medicine
[2] Social Insurance Funabashi Chuo Hospital,undefined
[3] Matsudo City Hospital,undefined
[4] Saiseikai Narashino Hospital,undefined
[5] Kikkoman Hospital,undefined
[6] National Hospital Organization Chiba Medical Center,undefined
[7] Sannou Hospital Medical Center,undefined
[8] Kimitsu Chuo Hospital,undefined
来源：
Hepatology International | 2013年 / 7卷
关键词：
Age; Gender; Genotype 1; HCV; Ribavirin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：144 / 152
页数：8
相关论文
共 50 条
  • [21] Early virologic response after peginterferon alpha-2a plus ribavirin or peginterferon alpha-2b plus ribavirin treatment in patients with chronic hepatitis C
    Di Bisceglie, A. M.
    Ghalib, R. H.
    Hamzeh, F. M.
    Rustgi, V. K.
    JOURNAL OF VIRAL HEPATITIS, 2007, 14 (10) : 721 - 729
  • [22] Peginterferon alpha-2b plus ribavirin for chronic hepatitis C virus mixed genotype infection
    Lin, Ching-Chung
    Wu, Chia-Hsien
    Chen, Huan-Lin
    Lin, I-Tsung
    Wang, Shen-Yung
    Wang, Tsang-En
    Wang, Horng-Yuan
    Shih, Shou-Chuan
    Bair, Ming-Jong
    ANNALS OF HEPATOLOGY, 2014, 13 (04) : 350 - 355
  • [23] Risk score based PEG Interferon alpha 2b and Ribavirin treatment response estimation model for genotype 1 chronic hepatitis C patients
    Jurczyk, K.
    Laurans, L.
    Karpinska, E.
    Wawrzynowicz-Syczewska, M.
    Parczewski, M.
    Boron-Kaczmarska, A.
    ADVANCES IN MEDICAL SCIENCES, 2011, 56 (02): : 165 - 171
  • [24] Impact of early viral kinetics on pegylated interferon alpha 2b plus ribavirin therapy in Japanese patients with genotype 2 chronic hepatitis C
    Nomura, H.
    Miyagi, Y.
    Tanimoto, H.
    Ishibashi, H.
    JOURNAL OF VIRAL HEPATITIS, 2009, 16 (05) : 346 - 351
  • [25] Effectiveness of peginterferon alpha-2a or -2b plus ribavirin in naive patients with hepatitis C infection
    Marquez-Peiro, Juan Francisco
    Valero-Alcocer, Victoria Eugenia
    Morales-Suarez-Varela, Maria Manuela del Mar
    Llopis-Gonzalez, Agustin
    Perez-Peiro, Carmen
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2008, 26 (03): : 135 - 140
  • [26] Peginterferon Lambda-1a/Ribavirin with Daclatasvir or Peginterferon Alfa-2a/Ribavirin with Telaprevir for Chronic Hepatitis C Genotype 1b
    Flisiak, Robert
    Kawazoe, Seiji
    Znoyko, Olga
    Assy, Nimer
    Gadano, Adrian
    Kao, Jia-Horng
    Lee, Kwan-Sik
    Zwirtes, Ricardo
    Portsmouth, Simon
    Dong, Yuping
    Xu, Dong
    Kumada, Hiromitsu
    Srinivasan, Subasree
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2016, 36 (11): : 635 - 643
  • [27] Pioglitazone improves virological response to peginterferon α-2b/ribavirin combination therapy in hepatitis C genotype 4 patients with insulin resistance
    Khattab, Mahmoud
    Emad, Mohammed
    Abdelaleem, Asharf
    Eslam, Mohammed
    Atef, Rabab
    Shaker, Yehia
    Hamdy, Lamia
    LIVER INTERNATIONAL, 2010, 30 (03) : 447 - 454
  • [28] A study to assess treatment with peginterferon alpha-2b and ribavirin in naive patients with genotype 1 chronic hepatitis C and slow virological response (SUCCESS study)
    Esteban, R.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S50 - S50
  • [29] Simple formula to predict response to peginterferon alpha2b and ribavirin combination therapy in genotype 1 chronic hepatitis C patients with high viral loads
    Itoh, Yoshito
    Nishimura, Takeshi
    Hashimoto, Hiroaki
    Yamaguchi, Kanji
    Niimi, Toshihisa
    Yokomizo, Chihiro
    Fujii, Hideki
    Minami, Masahito
    Yasui, Kohichiroh
    Mitsuyoshi, Hironori
    Okanoue, Takeshi
    Takehara, Tetsuo
    Hiasa, Yoichi
    Onji, Morikazu
    Yoshikawa, Toshikazu
    HEPATOLOGY RESEARCH, 2011, 41 (02) : 126 - 132
  • [30] Treatment of Chronic Hepatitis C Genotype 4 with Peginterferon alpha-2a plus Ribavirin
    Varghese, R.
    Al-Khaldi, J.
    Asker, H.
    Fadili, A. A.
    Al-Ali, J.
    Hesasn, F. A.
    HEPATO-GASTROENTEROLOGY, 2009, 56 (89) : 218 - 222
12345